Elfreda Jonker deep dives into three high-conviction ideas for the year ahead.
Alphinity has been included as a Responsible Investment Leader by the Responsible Investment Association Australasia in its landmark study.
We look back at the major drivers of returns in FY21 and important trends for FY22.
Philips’ global recall in sleep apnea masks presents a unique opportunity for Resmed to increase market share.
In light of the recent noise in the market from China, the Fed and the CPI print, Alphinity reflect on how their Funds are currently positioned.
Andrew Martin discusses his current thinking on Australian banks.
In this episode of Livewire’s Buy Hold Sell, Stuart Welch discusses whether it is time to top up or sell three underperforming blue chip stocks: CSL, Brambles and Coles.
Elfreda Jonker discusses why the current uncertainty in the market presents the perfect opportunity to look under the hood for alpha opportunities.